Rodrigo Modolo1,2, MD; Chun Chin Chang3, MD; Yoshinobu Onuma4, MD, PhD; Carl Schultz3, MD, PhD; Hiroki Tateishi5, MD, PhD; Mohammad Abdelghani1,6, MD; Yosuke Miyazaki5,3, MD, PhD; Jean-Paul Aben7, MSc; Marcel C.M. Rutten8, PhD; Michele Pighi9, MD; Abdelhak El Bouziani1, MD; Martijn van Mourik1, PhD; Pedro A. Lemos10,11, MD, PhD; Joanna J. Wykrzykowska1, MD, PhD; Fabio Sandoli Brito Jr10, MD, PhD; Cherif Sahyoun12, PhD; Nicolo Piazza9, MD, PhD; Hélène Eltchaninoff13, MD, PhD; Osama Soliman4, MD, PhD; Mohamed Abdel-Wahab6,14, MD, PhD; Nicolas M. Van Mieghem3, MD, PhD; Robbert J. de Winter1, MD, PhD; Patrick W. Serruys4, MD, PhD
1. Department of Cardiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands; 2. Department of Internal Medicine, Cardiology Division. University of Campinas (UNICAMP), Campinas, Brazil; 3. Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands; 4. Department of Cardiology, National University of Ireland, Galway, Ireland; 5. Division of Cardiology, Department of Clinical Science and Medicine- Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan; 6. The Heart Center, Segeberger Kliniken, Bad Segeberg, Germany; 7. Pie Medical Imaging, Maastricht, the Netherlands; 8. Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands; 9. Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada; 10. The Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil; 11. Hospital Israelita Albert Einstein, Sao Paulo, Brazil; 12. Philips Healthcare, Best, the Netherlands; 13. Cardiology Service, Rouen-Charles-Nicolle University Hospital Center, National Institute of Health and Medical Research U644, Rouen, France; 14. Cardiology Department, Heart Center Leipzig at the University of Leipzig, Leipzig, Germany
Transcatheter aortic valve implantation (TAVI) is undeniably invading the “surgical” space and expanding its indication. Over the last five years, there has been a real revolution in TAVI technology with the introduction of newer devices that aimed to simplify the procedure1. These swift advances have transformed the landscape in structural heart disease and culminated in a broader use of TAVI in clinical practice2,3. The procedure is not only spreading worldwide but is also becoming less aggressive for the patient with the so-called “minimalist approach”.
With the rise and consolidation of this minimally ...
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
Interventions for valvular diseaseTAVI
Read next article
Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification